PARP inhibitors

Pfizer TLZ 0.25 Pill - white capsule-shape

Generic Name: talazoparib

Pill with imprint Pfizer TLZ 0.25 is White, Capsule-shape and has been identified as Talzenna 0.25 mg. It is supplied by Pfizer Inc.

Talzenna is used in the treatment of Breast Cancer; Prostate Cancer and belongs to the drug class PARP inhibitors. Talzenna 0.25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Talzenna (Talazoparib)-Pfizer TLZ 0.25-0.25 mg-White-Capsule-shape

Talzenna
Generic Name: talazoparib
Imprint: Pfizer TLZ 0.25
Strength: 0.25 mg
Color: White
Size: N/A
Shape: Capsule-shape
Availability: Prescription only
Drug Class: PARP inhibitors
Pregnancy Category: N/A
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00069-0296
Inactive Ingredients:
Latest News
Related Drugs